Department of Health Science, Kampala International UniversitY, Uganda
Review Article
The Effect of Azithromycin and 4-Aminoquinoline-Based Regimens in COVID-19 Positive Pregnant Women: A Systematic Review
Author(s): Vian Namanya* and Kalema Bashir Amza
Introduction: Worldwide the efficacy and safety of Azithromycin and 4-Aminoquinoline regimen in the treatment of COVID-19 has remained uncertain in both pregnant and other mothers. Pregnancy complications studies are still lacking, although a high preterm birth rate due to the combination of this regimen has been reported which is mostly caused by iatrogenic preterm birth owing to the diagnosis of COVID-19 principally preterm cesarean deliveries and perinatal transmission may occur but seems rare. There is lack of evidence reporting an increase in the incidence of congenital abnormalities, an increase in stillbirth or neonatal death (miscarriages), Fetal Growth Restriction (FGR) among pregnant mothers with COVID-19.
Aim: This study aimed at systematically reviewing studies regarding the use of Azithromycin and 4-Aminoquinoline based regimens.. Read More»
DOI:
DOI: 10.37421/2155-6113.2022.13.892
Journal of AIDS & Clinical Research received 5264 citations as per Google Scholar report